AeroLeads people directory · profile

Todd Davis Email & Phone Number

CEO, Ligand Pharmaceuticals | Life Sciences Executive & Investor at Ligand Pharmaceuticals
Location: Jupiter, Florida, United States 14 work roles 2 schools
LinkedIn matched
✓ Verified May 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
CEO, Ligand Pharmaceuticals | Life Sciences Executive & Investor
Location
Jupiter, Florida, United States

Who is Todd Davis? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Todd Davis is listed as CEO, Ligand Pharmaceuticals | Life Sciences Executive & Investor at Ligand Pharmaceuticals, based in Jupiter, Florida, United States. AeroLeads shows a matched LinkedIn profile for Todd Davis.

Todd Davis previously worked as Chief Executive Officer & Director at Ligand Pharmaceuticals and Director at Ligand Pharmaceuticals. Todd Davis holds Mba, Business from Harvard University.

Company email context

Email format at Ligand Pharmaceuticals

This section adds company-level context without repeating Todd Davis's masked contact details.

Ligand Pharmaceuticals

Review company-level records connected to Todd Davis before choosing the right outreach path.

Profile bio

About Todd Davis

I am a life sciences executive with more than 30 years of operational and investment experience. Throughout my career, I have created eight pharma businesses and a royalty/credit focused investment business that has raised over $5bn. I have also been personally involved in over $4bn in healthcare financings, including growth equity, public equity turnarounds, structured debt and royalty acquisitions. I have also led, structured and closed over 40 additional IP licenses, as well as royalty-debt deals and have restructured and turned around multiple private and public companies.With insight from pharmaceutical industry commercial and operational roles, exceptional deal-making experience and an understanding of capital markets, I partner with life science experts to realize value in assets that have high potential, are emerging, have been undercapitalized, misunderstood or undervalued. This strategy allows me to consistently achieve exceptional value and investor returns. My early roles at Abbot Laboratories and Elan Pharmaceuticals gave me excellent operational experience in healthcare technology. Moving to Private Equity and my time with Apax Partners represented a steep learning curve as well as a pivotal stage in my career. I instigated the firm’s entry into the specialty pharmaceutical sector and commercial stage investing; highlights included average equity returns of greater than 40% IRR in primary deals associated with new investment areas. Since then, I’ve been at the vanguard of innovation and growth in the industry, with extensive experience across both development and commercial-stage business investments. Subsequent to Apax, I co-founded Healthcare Royalty Partners and Royalty Rx Capital and have pioneered project and royalty finance in the biopharmaceutical sector. Structure is just the tool though - what really matters are assets, science and management. I enjoy working with experienced life science clinicians and executives who are launching, acquiring, or restructuring business ventures with high-potential products and technologies.

Current workplace

Todd Davis's current company

Company context helps verify the profile and gives searchers a useful next step.

Ligand Pharmaceuticals
Ligand Pharmaceuticals
CEO, Ligand Pharmaceuticals | Life Sciences Executive & Investor
AeroLeads page
14 roles · 47 years

Todd Davis work experience

A career timeline built from the work history available for this profile.

Chief Executive Officer & Director

Current

Jupiter, Florida, US

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Dec 2022 - Present

Director

Jupiter, Florida, US

High-growth company that has aggregated economic rights to some of the world's most important medicines.

Mar 2007 - Dec 2022

Director

Current

London, GB

Founding board member of this start-up gene therapy business that manufactures viral vectors and gene-modified cells, enabling safe and swift transition from laboratory to clinical trials and scalable processes.

2021 - Present ~5 yrs 4 mos

Chairman

Current
Benuvia Holdings Inc.

Financing and development of low-risk assets with high clinical value to improve the quality of life for patients with rare and underserved diseases.

Nov 2019 - Present

Founder & Managing Partner

Current
Royaltyrx Capital, Llc

Biopharma Investment Fund, syndicating family office capital for high return/low risk special situations.

Sep 2018 - Present

Director

Current

Wayne, PA, US

Founding board member of this private biopharmaceutical business serving patients with debilitating, rare genetic diseases through development and commercialization of life-changing, pathogenetically targeted therapies.

Nov 2017 - Present

Chairman

South San Francisco, California, US

Board member of this innovative oral vaccine company. Vaxart’s proprietary VAAST™ oral vaccine platform uses state-of-the-art recombinant technology that allows modular creation of a wide range of vaccines.

2019 - Mar 2023

Director

Biodelivery Sciences International

Commercial stage specialty pharmaceutical company dedicated to patients living with chronic pain.

May 2018 - Mar 2022

Founder & Managing Partner

Stamford, Connecticut, US

Investment firm that purchases royalties and uses debt-like structures to invest in commercial or near-commercial stage assets.

Jan 2007 - Jan 2018

Partner

San Francisco, CA, US

Private Equity investment firm made up of a fund of funds, secondary investments and a healthcare direct investment business.

2004 - 2006 ~2 yrs

Partner

GB

UK headquartered invernational Private Equity company that creates value by supporting transformational improvements in portfolio companies.

2001 - 2004 ~3 yrs

Vice President

Dublin 2, IE

International pharmaceutical company based in Dublin, Ireland, which had major interests in the United States and was listed on the New York Stock Exchange.

1997 - 2001 ~4 yrs

Naval Officer

Washington, DC, US

1979 - 1990 ~11 yrs
2 education records

Todd Davis education

Mba, Business

Harvard University

Education record

United States Naval Academy
FAQ

Frequently asked questions about Todd Davis

Quick answers generated from the profile data available on this page.

What company does Todd Davis work for?

Todd Davis works for Ligand Pharmaceuticals.

What is Todd Davis's role at Ligand Pharmaceuticals?

Todd Davis is listed as CEO, Ligand Pharmaceuticals | Life Sciences Executive & Investor at Ligand Pharmaceuticals.

Where is Todd Davis based?

Todd Davis is based in Jupiter, Florida, United States while working with Ligand Pharmaceuticals.

What companies has Todd Davis worked for?

Todd Davis has worked for Ligand Pharmaceuticals, Virocell Biologics, Benuvia Holdings Inc., Royaltyrx Capital, Llc, and Palvella Therapeutics.

How can I contact Todd Davis?

You can use AeroLeads to view verified contact signals for Todd Davis at Ligand Pharmaceuticals, including work email, phone, and LinkedIn data when available.

What schools did Todd Davis attend?

Todd Davis holds Mba, Business from Harvard University.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.